1. The efficacy of blueberry and grape seed extract combination on triple therapy for Helicobacter pylori eradication: a randomised controlled trial.
- Author
-
Chua CS, Yang KC, Chen JH, Liu YH, Hsu YH, Lee HC, and Huang SY
- Subjects
- Adult, Aged, Amoxicillin administration & dosage, Anti-Bacterial Agents administration & dosage, Anti-Bacterial Agents therapeutic use, Anti-Ulcer Agents administration & dosage, Anti-Ulcer Agents therapeutic use, Bacterial Adhesion, Clarithromycin administration & dosage, Drug Therapy, Combination, Esomeprazole administration & dosage, Female, Grape Seed Extract chemistry, Helicobacter pylori, Humans, Male, Middle Aged, Amoxicillin therapeutic use, Blueberry Plants chemistry, Clarithromycin therapeutic use, Esomeprazole therapeutic use, Grape Seed Extract pharmacology, Helicobacter Infections drug therapy
- Abstract
Helicobacter pylori is a major risk factor for gastritis, gastric ulcers and gastric cancer. Traditional therapy with proton pump inhibitor and antibiotics is regarded as optimal for H. pylori eradication whereas, the eradication rate is unsatisfactory. Studies have reported that cranberry may inhibit H. pylori adhesion to the human gastric mucus but lack of other berry extracts have been evaluated in clinical study. Thus, a 9-week add-on randomised controlled trial was conducted to explore the impact of blueberry and grape seed extract (BGE) combinations traditional therapy for H. pylori eradication. In results, we found that there was no significant difference of eradication rate between the berry extract group and placebo group in the intention-to-treat analysis and in the per-protocol analysis (94.64% versus 84.62%, p = 0.085). Diarrhoea, constipation and epigastric pain were observed increasing during ingestion of the berry extract in some cases. In conclusion, this study indicated that no significant difference existed between the BGE extract group and placebo group in eradication rate under triple therapy.
- Published
- 2016
- Full Text
- View/download PDF